-
Aravive Announces Management Changes
americanpharmaceuticalreview
January 13, 2020
Aravive has announced the appointment of Rekha Hemrajani as president, chief executive officer and director of the company. Jay Shepard, who last year announced plans to step down as Aravive’s CEO, will transition to the role of chairman of the board of d
-
Mirati Announces Executive Management Changes
americanpharmaceuticalreview
January 09, 2020
Mirati Therapeutics has announced changes to their executive management team, effective immediately. Mirati continues to accelerate the development of the KRAS and sitravatinib programs ...
-
Few Oncologists Refer Patients to Weight Management Programs
drugs
June 06, 2019
Few Oncologists Refer Patients to Weight Management Programs.
-
Meds for Weight Management Underutilized Among Veterans
drugs
May 29, 2019
Meds for Weight Management Underutilized Among Veterans.
-
PCI Readies for Growth with Upper Management Changes
contractpharma
May 21, 2019
Roberts, Evans, Schroeder and Ritchie to lead new PCI initiatives.
-
TPlus signs MoU with Yonsei University for dose management
biospectrumasia
October 25, 2018
TPLUS has built up a therapeutic imaging gadget called ‘Dosetracker.’
-
PAREXEL expands regulatory management services
biospectrumasia
October 23, 2018
PAREXEL partners with EMC to provide regulatory management services
-
FDA Approves First Non-Opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults
americanpharmaceuticalreview
May 18, 2018
The U.S. Food and Drug Administration (FDA) approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.
-
Free webinar: EU risk management for oncology medicines
pharmafile
May 15, 2018
In our latest free webinar, listen to Dr William Richardson, Medical Advisor at NDA Group, speak on how to best implement the revised GVP module (V) concerning risk management in the interests of patients throughout the life-cycle of a medicine.